$5.28
-0.320 (-5.71%)
At Close: Jun 03, 2026
Helen of Troy (HELE) Soars 5.4%: Is Further Upside Left in the Stock?
09:13am, Friday, 23'rd Dec 2022 Zacks Investment Research
Helen of Troy (HELE) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near ter
Dividend Champion, Contender, And Challenger Highlights: Week Of December 4
05:29am, Sunday, 04'th Dec 2022 Seeking Alpha
Weekly summary of dividend activity for Dividend Champions, Contenders, Challengers. Read more to see companies with upcoming ex-dividend dates.
Nu Skin (NUS) Up 28.5% Since Last Earnings Report: Can It Continue?
04:31pm, Friday, 02'nd Dec 2022 Zacks Investment Research
Nu Skin (NUS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Nu Skin (NUS) Up 28.5% Since Last Earnings Report: Can It Continue?
12:48pm, Friday, 02'nd Dec 2022
Nu Skin (NUS) reported earnings 30 days ago. What's next for the stock?
Abercrombie & Fitch To Rally 21%? Plus This Analyst Predicts $237 For Autodesk
11:54am, Wednesday, 23'rd Nov 2022 Benzinga
Telsey Advisory Group raised the price target on Abercrombie & Fitch Co. (NYSE: ANF) from $25 to $27. Abercrombie & Fitch shares fell 1.2% to $22.34 in pre-market trading.
Keybanc slashed Autodesk,
Zacks Market Edge Highlights: WBA, TROW, ITW, NUS, WSM
09:39am, Thursday, 17'th Nov 2022 Zacks Investment Research
WBA, TROW, ITW, NUS and WSM have been highlighted in this Market Edge article.
Looking for High Yields? Check the Dividend Aristocrats
08:47pm, Wednesday, 16'th Nov 2022 Zacks Investment Research
Getting a 5% yield isn't easy but here's some tips for finding the stocks.
Kellogg, Palo Alto Networks, Roku And Other Big Losers From Thursday
10:06am, Friday, 04'th Nov 2022 Benzinga
U.S. stocks closed lower on Thursday, with the Dow Jones dropping more than 100 points. Here is the list of some big stocks recording losses in the previous session.
Lincoln National Corporation (NYS
Why Greenhill Shares Climbed Around 25%; Here Are 100 Biggest Movers From Yesterday
08:41am, Friday, 04'th Nov 2022 Benzinga
Gainers
Huadi International Group Co., Ltd. (NASDAQ: HUDI) shares jumped 242.8% to close at $105.72 on Thursday. The company announced a strategic plan to enter into the clean energy industry.
Acutus
Why Lincoln National Shares Are Trading Lower By 31%? Here Are 72 Stocks Moving In Thursday's Session
06:35pm, Thursday, 03'rd Nov 2022 Benzinga
Gainers
Huadi International Group Co., Ltd. (NASDAQ: HUDI) gained 64% to $50.60.
Virax Biolabs Group Limited (NASDAQ: VRAX) surged 34% to $2.25 after the company announced the distribution of a RSV-I
Nu Skin Enterprises (NUS) Q3 Earnings and Revenues Lag Estimates
10:45pm, Wednesday, 02'nd Nov 2022 Zacks Investment Research
Nu Skin (NUS) delivered earnings and revenue surprises of -39.74% and 5.57%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Nu Skin Enterprises, Inc. (NUS) Q3 2022 Earnings Call Transcript
09:23pm, Wednesday, 02'nd Nov 2022
Nu Skin Enterprises, Inc. (NYSE:NUS ) Q3 2022 Earnings Conference Call November 2, 2022 5:30 PM ET Company Participants Scott Pond - Vice President of Investor Relations Ryan Napierski - President & C
Nu Skin Enterprises (NUS) Q3 Earnings and Revenues Lag Estimates
08:20pm, Wednesday, 02'nd Nov 2022
Nu Skin (NUS) delivered earnings and revenue surprises of -39.74% and 5.57%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Nu Skin (NUS) Queued for Q3 Earnings: Things to Consider
04:53pm, Monday, 31'st Oct 2022 Zacks Investment Research
Nu Skin's (NUS) Q3 performance will likely reflect continued economic uncertainty, prolonged COVID-associated factors, unfavorable currency rates and geopolitical conflicts.
Kellogg's (K) Q3 Earnings Upcoming: Here's All You Should Note
03:09pm, Monday, 31'st Oct 2022 Zacks Investment Research
Kellogg's (K) third-quarter 2022 results are likely to reflect gains from the company's revenue growth management actions, whereas cost inflation and supply-chain bottlenecks are likely to have been a
Sign In
Buy NUS